This process releases tumor antigens and damage-associated molecular patterns (DAMPs), which activate dendritic cells and subsequently activate and recruit T cells, particularly CD8+ T cells, thereby enhancing the anti-tumor immune response. Here, CD8A is linked to neoplasm.